Fan Favorite: Can Medical Practices Offer Stem Cells or Exosomes with Jordan Plews, PhD

The buzz around stem cells and exosomes continues to grow, but so do the legal and regulatory questions. In this fan favorite episode, Dr. Jordan Plews shares what medical practices should understand about these products, including FDA concerns, off-label risks, and why compliance matters just as much as innovation. Chapters [00:00] Intro [01:06]  Banter   [04:56]  Guest background [09:40]  What are stem cells and exosomes? [11:00] What is the use risk for live cells and a stem cells?   [13:00] Is there a product out there similar to stem cells?   [15:30] Can a medical practice offer stem cells or exosomes? [18:44] What are the risks of offering stem cells and exosomes? [20:08] What are patient and provider risks of stem cells and exosomes? [22:00] How are medical practices using stem cells and exosomes? [23:00] How would you advise practices looking to offer stem cells and exosomes? [26:51] Access+ [27:26]  Legal Takeaways   [30:26]  Outro Watch full episodes of our podcast on our YouTube channel:    / @byrdadatto   Stay connected for the latest business and health care legal updates: Website (https://byrdadatto.com/) Facebook (  / byrdadatto  ) Instagram (  / byrdadattolaw  ) LinkedIn (  / byrdadatto  )